Catheter Precision, Inc.
VTAK
$0.30
-$0.0262-8.03%
AMEX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -4.03% | 55.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.03% | 55.21% | |||
| Cost of Revenue | 0.00% | 10.00% | |||
| Gross Profit | -4.35% | 60.47% | |||
| SG&A Expenses | 12.49% | 7.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.47% | 8.29% | |||
| Operating Income | -13.27% | -6.72% | |||
| Income Before Tax | -91.76% | 39.64% | |||
| Income Tax Expenses | -123.05% | -- | |||
| Earnings from Continuing Operations | 28.13% | -36.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.13% | -36.60% | |||
| EBIT | -13.27% | -6.72% | |||
| EBITDA | -16.07% | -8.20% | |||
| EPS Basic | 68.45% | 43.44% | |||
| Normalized Basic EPS | -57.36% | 86.96% | |||
| EPS Diluted | 68.45% | 43.44% | |||
| Normalized Diluted EPS | -57.36% | 86.96% | |||
| Average Basic Shares Outstanding | 18.87% | 362.87% | |||
| Average Diluted Shares Outstanding | 18.87% | 362.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||